Esbriet (pirfenidone) Educational Webcast
During the webcast, you will learn the potential benefits and risks of Esbriet®, results from the Esbriet studies in IPF, and the support available to guide you through treatment.
The Esbriet program will be hosted by Dr. Talmadge King, Chair of the Department of Medicine at the University of California, San Francisco. Dr. King is an expert in the care of IPF.
The webcasts will take place on February 24, 2015. Choose the time that fits your schedule. You will need internet and phone access to attend the program.
Time: 11:00 a.m.-12:00 p.m. EST and 7:00 p.m.-8:00 p.m. EST
To register for one of these programs, please click on the link below or enter the following address in your browser: esbrietpatientwebcast.com
You may also call 855.888.4866 between the hours of 9:00 a.m. and 5:00 p.m. EST to register.